Heart Failure with Mildly Reduced Ejection Fraction
📧 Sign up to get email alerts when something new happens for Heart Failure with Mildly Reduced Ejection Fraction.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity [Phase 3]
A Phase 3 trial evaluating Maridebart Cafraglutide for heart failure with preserved or mildly reduced ejection fraction in people with obesi…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of NT-88 [NA]
Clinical trial update: NT-88 is being studied to assess safety and efficacy in heart failure with mildly reduced ejection fraction; the tria…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Pharmacological Optimization in Prevention in Heart Failure: A Sex-gap? [Phase 4]
An update on a Phase 4 trial evaluating pharmacological optimization to prevent heart failure, including consideration of sex differences; r…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: PBMC as Biomarkers of Diabetic Cardiomyopathy
A clinical trial is evaluating peripheral blood mononuclear cells as biomarkers for diabetic cardiomyopathy and related heart failure condit…
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: Sodium-Glucose Cotransporter 2 Inhibitor Use in a National Heart Failure Telemonitoring Program
This clinical trial update reports the completion of a national telemonitoring program evaluating the use of SGLT2 inhibitors in heart failu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Infusing Needed Iron to Target Insufficiency in Adults Treated for Evidence of Heart Failure [NA]
This Kaiser Permanente trial tests intravenous iron to treat iron deficiency in adults with evidence of heart failure and its subtypes; the …
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Investigation on the Impact of Finerenone on Myocardial Remodeling in Patients With Diabetic Kidney Disease and Heart Failure [Phase 4]
Phase 4 clinical trial investigating the effect of finerenone on myocardial remodeling in patients with diabetic kidney disease and heart fa…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Treating Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: Ablation or Medication [NA]
This clinical trial update reports a study recruiting patients to compare ablation versus medical therapy for treating atrial fibrillation i…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Precision Subtyping and Prognostic Study of Heart Failure Based on Multi-Omics Integration and Clinical Indicators: A Prospective Single-Center Cohort Study
A prospective, single-center cohort study aiming to subtype heart failure patients using multi-omics data and clinical indicators to refine …
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: Descriptive Study of Circulating Gene or Protein Inflammatory Biomarkers and Bioimpedance Parameters in a Population of Patients Hospitalized for Decompensated Heart Failure With Preserved or Mildly Reduced Cardiac Function
Describes a descriptive clinical trial evaluating circulating inflammatory biomarkers and bioimpedance parameters in patients hospitalized f…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Effectiveness and Safety of Uptitration of Guideline Directed MEdical Therapy in Heart Failure With Reduced Ejection Fraction With Limited Kidney Function Assessments [NA]
This clinical trial update examines the effectiveness and safety of uptitrating guideline-directed medical therapy in patients with heart fa…
-
CLINICAL_TRIALS trial_result · 2025-09-30Clinical Trial Update: Safety and Tolerability Study of XXB750 in Heart Failure Participants With Reduced or Mildly Reduced Ejection Fraction (HFrEF/HFmrEF) [Phase 1]
Phase 1 safety and tolerability study of XXB750 in heart failure patients with reduced or mildly reduced ejection fraction has been complete…
-
CLINICAL_TRIALS trial_result · 2025-07-17Clinical Trial Update: Frailty and Outcomes in Older Heart Failure Patients With Ejection Fraction >40%
An update on an ongoing clinical trial evaluating frailty and outcomes in older heart failure patients with EF >40%, covering heart failure …
-
CLINICAL_TRIALS research · 2025-07-11Clinical Trial Update: A Study of IBI362 in Subjects With HFpEF or HFmrEF Combined With Obesity [Phase 2]
A Phase 2 clinical trial evaluating IBI362 in patients with obesity and heart failure with preserved ejection fraction (HFpEF) or mildly red…
-
CLINICAL_TRIALS trial_result · 2025-02-25Clinical Trial Update: Iron Deficiency in Patients With Heart Failure and Reduced and Mildly Reduced Ejection Fraction
This clinical trial evaluated iron deficiency in patients with heart failure with reduced ejection fraction (HFrEF) and heart failure with m…
-
CLINICAL_TRIALS research · 2022-12-09Clinical Trial Update: Cardiometabolic Effects of Dapagliflozin in Heart Failure With Reduced or Mildly Reduced Ejection Fraction [Phase 2]
Phase 2 clinical trial evaluating the cardiometabolic effects of dapagliflozin in heart failure with reduced or mildly reduced ejection frac…